12th Session of India-Belarus Inter-Governmental Commission held in New Delhi (See 'Corp Brief') India to host Ministerial Meeting of International Coconut Community in Kochi (See 'Corp Brief') CPC/Limitation - Entries in books of account & balance sheets can constitute acknowledgment of liability u/s 18 of Limitation Act, provided they indicate subsisting jural relationship when read with surrounding circumstances: SC LB (See 'Legal Desk') India Post releases Commemorative Postage Stamp on Pioneer of Biogas Technology (See 'Corp Brief') NICDC Pavilion showcases AP's Greenfield Industrial Smart Cities (See 'Corp Brief') CCPA imposes Penalty of Rs 20 Lakh on ExportersIndia.com (See 'Corp Brief') IBC - RP required to function independently & cannot act according to whims & fancies of a dominant Financial Creditor - CoC's majority decision to replace RP cannot be interfered with by another Financial Creditor holding minority voting share: NCLAT (See 'Legal Desk') IITF 2026 - EPFO Lounge & ESIC Pavilion inaugurated (See 'Corp Brief') Giriraj Singh visits Welspun World's State-of-the-Art Manufacturing Units in Kutch (See 'Corp Brief') PMLA - Status of secured creditor & initiation of prior recovery proceedings under SARFAESI Act do not exempt a property from attachment under PMLA, when property constitutes proceeds of crime: SAFEMA Tribunal (See 'Legal Desk') Indian Business leaders and Start ups to participate in the India-Egypt Business Forum (See 'Corp Brief') NRIDA selected for Medal for Innovation in Road Technology (See 'Corp Brief') PMLA - Objectives of special anti-money laundering law supersede private commercial security interests - properties linked to criminal activities liable to provisional & final attachment: SAFEMA Tribunal (See 'Legal Desk') Shilp Samagam Mela 2026 at Dilli Haat records Cumulative Sales of Over Rs 88.36 Lakh (See 'Corp Brief') National Tribal Literary Festival concludes with Emphasis on Preserving Oral Traditions (See 'Corp Brief') SEBI - Freezing the Appellants' demat & bank accounts pending deposit of alleged unlawful gains of Rs. 28.12 crore, is valid: SAT (See 'Legal Desk') MoS calls for strengthening India-Italy collaborative research for innovation (See 'Corp Brief') Ministry of Culture invites Partners to Build India's Creative Economy Together (See 'Corp Brief') DoT organises First All India Conference on Official Language 2026 in New Delhi (See 'Corp Brief') Centre strengthens healthcare network through 3 Urban Primary Health Centres (See 'Corp Brief') TDB-DST signs agreement with Astrome to develop sovereign space-based AI-ELINT constellation (See 'Corp Brief') 2nd Edition of the National Tribal Literary Festival 2026 begins in New Delhi (See 'Corp Brief') CCRAS-CARI and University of Delhi sign MoU to document medicinal plant diversity (See 'Corp Brief') RTI - Per Sections 2 & 3 of the Act, CPIO is not obligated to compile, analyze, correlate, or generate fresh datasets from disparate records in specific format desired by applicant: IBBI (See 'Legal Desk') Naturopathy Day 2026: Scientific Research strengthens India's Nature-Based Healthcare Ecosystem (See 'Corp Brief') India and Italy to deepen scientific cooperation through bilateral engagements (See 'Corp Brief') Yadav holds interaction with LeadIT Industry Members and Project Partners (See 'Corp Brief') SEBI - Stay on 5-year debarrment unwarranted where Appellant fails to make out prima facie case - unusual trading pattern noted along with admitted receipt of certain funds from connected entities: SAT (See 'Legal Desk') India strengthens Regional Health Partnerships as First BIMSTEC summit (See 'Corp Brief') CBN dismantles clan lab of mephedrone in Uttar Pradesh (See 'Corp Brief') IPR - Dominant element of composite mark is entitled to standalone protection and party cannot resile from concession made on court record without seeking formal recall of order: HC (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

MoS reaffirms India's commitment to global pharmaceutical standardization

Published: Feb 06, 2025

By TIOLCorplaws News Service

NEW DELHI, FEB 06, 2025: UNION Minister of State for Health and Family Welfare, Anupriya Patel delivered the keynote address at the 15th International Meeting of World Pharmacopoeias (IMWP), hosted by the Indian Pharmacopoeia Commission (IPC) under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with the World Health Organization (WHO), here today. The meeting brought together global pharmacopoeial leaders, regulatory authorities, and industry stakeholders to deliberate on key issues related to pharmaceutical standards and harmonization.

Addressing the gathering, Patel reaffirmed India's commitment to global pharmaceutical standardization and regulatory convergence. She highlighted India's role as the "Pharmacy of the World" and emphasized the importance of ensuring access to high-quality medicines globally. She stated that the IMWP serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization.

On this occasion, the Union Minister also released the IPC Newsletter 2024 and a special IPC video film, which showcase India's advancements in pharmacopoeial science and the Commission's efforts in ensuring high-quality pharmaceutical standards. The video film can be accessed at the following link: https://www.youtube.com/watch?v=MCdAZodvOSM .

Punya Salila Srivastava, Secretary, Ministry of Health and Family Welfare, underscored the significance of global partnerships in strengthening pharmaceutical quality standards. She reiterated India's efforts in aligning regulatory frameworks with international best practices and ensuring the availability of safe and effective medicines worldwide.

Dr. Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director, IPC, and Drugs Controller General (India), highlighted IPC's contributions in setting global benchmarks in pharmacopoeial science. He elaborated on IPC's initiatives, including the IP Online platform, which enhances accessibility and usability of Indian Pharmacopoeia standards. He emphasized the role of scientific advancements and regulatory cooperation in shaping global pharmaceutical standards.

Dr. Roderico H. Ofrin, WHO Representative to India, commended India's leadership in pharmacopoeial standard-setting and emphasized the importance of regulatory harmonization in ensuring patient safety and public health.

The 15th IMWP is set to facilitate discussions on key focus areas, including:

- Updates on recommendations from the 14th IMWP and review of progress on harmonization initiatives.

- Emerging issues in impurity assessment (Q3) and the implications of ICH Q6 guidelines on pharmacopoeial monograph specifications.

- Defining the IMWP Charter to establish a long-term governance structure for the forum.

- Enhancing collaboration among global pharmacopoeias and regulatory bodies, with updates from the Pharmacopoeial Discussion Group (PDG).

- Promotion of environmental sustainability in pharmacopoeial practices and pharmaceutical manufacturing standards.

- Finalization of reports for the 15th IMWP and preparatory discussions for the 16th IMWP.

The deliberations during the IMWP will reinforce the role of pharmacopoeias in ensuring the quality, safety, and efficacy of medicines. The outcomes of the meeting will guide future collaborations in standard-setting and regulatory harmonization.

The 15th IMWP, which commenced today, will conclude on 7th February 2025. The discussions held over these three days will set the stage for further strengthening global pharmacopoeial cooperation and enhancing pharmaceutical quality assurance.

TIOL CORP SEARCH

TIOL GROUP WEBSITES